Novo Nordisk has tested a more effective weight loss treatment

Date:

Share this article:

Del denne artikel:

A large-scale trial of a new combination drug for type 2 diabetes may influence future treatment options.

Novo Nordisk has applied for approval in the United States for the drug CagriSema as a weight loss treatment in combination with diet and exercise.

If approved, it could be used in the same way as Wegovy.

At the same time, the company plans to test the medication against tirzepatide from Eli Lilly.

The market for this type of treatment is developing rapidly, with several companies competing to produce the most effective drugs.

Also read: Trump’s preferred sport is shared with his granddaughter Kai

The results come from the phase 3 trial REIMAGINE 2, which has not yet been published in a scientific journal, according to Medical News Today.

Results from the study

The trial included 2,728 people with type 2 diabetes who had not achieved sufficient results with metformin.

At the start, participants had an average long-term blood sugar (HbA1c) level of 8.2 percent and an average weight of 101 kilograms.

Over 68 weeks, participants received either CagriSema, the individual components administered separately, or a placebo.

Also read: Actor’s death brings renewed focus to colorectal cancer symptoms

According to Novo Nordisk’s data reported by Medical News Today, long-term blood sugar levels decreased by 1.91 percentage points in those who received the highest dose of CagriSema.

Among those who received semaglutide alone, the reduction was 1.76 percentage points.

Body weight decreased by an average of 14.2 percent with CagriSema, compared with 10.2 percent with semaglutide alone.

What does the medication contain?

CagriSema combines semaglutide and cagrilintide. Both substances affect hormones that regulate appetite, satiety, and blood sugar levels.

Also read: New research: Bedroom temperature affects the heart

An independent expert interviewed by Medical News Today emphasized that the results come from the manufacturer itself.

Further independent studies are therefore needed to assess effectiveness and side effects.

Only with additional documentation will it be possible to determine whether the treatment is genuinely superior to current options.

Sources: Medical News Today.

Also read: Doctor reveals when you should stop drinking coffee to sleep better

Also read: No gym required: Nine cardio exercises you can do at home

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

Study makes major finding: Every extra hour of unbroken sitting raises cancer death risk by 10%

New research suggests the harm holds even in people who exercise regularly.

If you take amlodipine or felodipine, you may need to avoid 4 foods

The interaction is well documented, but the risk depends heavily on which drug you take.

How pineapple can affect your body if you eat it every day

Pineapple can be an easy way to include more fruit in your daily diet while providing several important...

Pharmaceutical residues could be polluting the aquatic environment

Pharmaceutical residues can end up in the aquatic environment after the body has absorbed what it needs.

Study makes major finding: Every extra hour of unbroken sitting raises cancer death risk by 10%

New research suggests the harm holds even in people who exercise regularly.

If you take amlodipine or felodipine, you may need to avoid 4 foods

The interaction is well documented, but the risk depends heavily on which drug you take.

How pineapple can affect your body if you eat it every day

Pineapple can be an easy way to include more fruit in your daily diet while providing several important...